Theravance Biopharma, Inc. (TBPH)
18.48
-0.07
(-0.38%)
USD |
NASDAQ |
Dec 08, 12:01
Theravance Biopharma Shareholders Equity (Quarterly): 232.68M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 242.22M |
| Skye Bioscience, Inc. | 32.84M |
| FibroGen, Inc. | -17.03M |
| Myomo, Inc. | 14.63M |
| VYNE Therapeutics, Inc. | 32.09M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 415.46M |
| Total Liabilities (Quarterly) | 182.78M |
| Debt to Equity Ratio | 0.1917 |
| Current Ratio | 9.482 |
| Net Debt Paydown Yield | 0.06% |